{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.2486G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "2486"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation in the kinase domain"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005139"
  },
  "Experiment Method": [
    {
      "Assay Method": "Apoptosis assay with hydrogen peroxide",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 (implied)",
        "Description": "Experiments on apoptosis induced by hydrogen peroxide and proteolysis inhibitor effects."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.2486G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased degradation",
          "Result Description": "I2020T showed impaired protective effect against apoptosis; proteolysis inhibitors restored protective capacity."
        },
        {
          "Variant": "NM_001126112.3:c.2486G>A (wild-type control)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced protectivity",
          "Result Description": "Knockdown of wild-type LRRK2 reduced protective capacity against apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 used as a positive control for protective effects."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or untreated cells used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression above baseline levels (implied by proteolysis inhibitor restoration).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression below baseline levels (implied by impaired protective effects).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Apoptosis assays are standard for studying neurodegenerative diseases like Parkinson's."
      }
    }
  ]
}